AIM
TMO icon

Acrospire Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Acrospire Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$174K – 1295
2017
Q2 		$174K Buy
1,000
+400
+67% +$67.2K 0.16% 37
2017
Q1 		$92K Sell
600
-500
-45% -$76.4K 0.08% 372
2016
Q4 		$155K Buy
1,100
+500
+83% +$73.7K 0.06% 575
2016
Q3 		$95K Buy
600
+200
+50% +$30.8K 0.06% 601
2016
Q2 		$59K Buy
400
+200
+100% +$29.5K 0.04% 931
2016
Q1 		$28K Buy
+200
New +$26.8K 0.02% 1359

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acrospire Investment Management's TMO Position: Q3 2017 in Review

Acrospire Investment Management sold out of Thermo Fisher Scientific (TMO) in Q3 2017, closing a stake of 1,000 shares — an estimated $174K sold.

Acrospire Investment Management first reported a position in TMO in Q1 2016 and held it in 6 quarters. The position peaked at $174K in Q2 2017. 1,162 funds tracked by Wall St. Rank hold TMO as of Q3 2017.

  • Acrospire Investment Management reported no remaining Thermo Fisher Scientific position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,000 Thermo Fisher Scientific shares in Q3 2017, an estimated $174K.
  • Acrospire Investment Management first reported a position in Thermo Fisher Scientific in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Thermo Fisher Scientific position peaked at $174K in Q2 2017.
  • 1,162 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.